{"name":"Surbhi Sidana, MD","slug":"surbhi-sidana-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQb1hlSTNMa3VxMWFqNm5rZ2p3ZnZKbGRTUEhKa1U2MllPQ2dVQ0ZwSUZjQThMdGRMZHFsek5XWWJmaXl3NFQ5YWFvaUV0d19Uck9mRER4MUdOekN5ZWx6RkdOcXhsaGE1Ti12T3M3NG16RlRPV1lsYnMzc1JScDh2U05iZGE0NmdmODBsY1lFN0p4aUlRZko2QUwxLUVrZ1BJckowSHM0SjYwZlVuVjFHS2lGd0tSeDRkMXhkYzM3VHFkdk96Qm5JTA?oc=5","date":"2024-10-21","type":"regulatory","source":"OncLive","summary":"FDA Approves IDH1/2+ Companion Diagnostic for Vorasidenib in Grade 2 Astrocytoma or Oligodendroglioma - OncLive","headline":"FDA Approves IDH1/2+ Companion Diagnostic for Vorasidenib in Grade 2 Astrocytoma or Oligodendroglioma","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPQ0FUdU1WYk5JZjBmd3JpcjEwREVtdFdQWjFoX0t1M2ZMLTNUeV91ZVNUbkRyZlJRMEV5UjVwS1VZSFRfbTA1bUdBNXFwTklYS0RIMWpSaDlCUi02V0tySjZfWGpCWFZ2aTFRZ3R6MTdla3hFSDhPVnEyODEtbmMzMDBhUTlRWVFXSFBzQkpPRFpPT2lxUWNzRTFJOWtiZ0stMmRCMUdiVXVDQ0FaVnI3eGU3Rll2cUxIekktZUE4Tko?oc=5","date":"2023-12-12","type":"pipeline","source":"fiercepharma.com","summary":"ASH: J&J, Sanofi square off in newly diagnosed multiple myeloma, with one med showing 'unprecedented' efficacy - fiercepharma.com","headline":"ASH: J&J, Sanofi square off in newly diagnosed multiple myeloma, with one med showing 'unprecedented' efficacy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQSG1ES01sZUgwOE1ibkd6Z05aVHVkUmxPUlF0N041aS1VSDdoUEJVQ28xU2ViN3VfQVVKRUdaM0tXcjB4Y2VVNGx5Mno3TERHX3NYMlFJNjhUOG91dzVLRWJDVlZGMEdQWUstX3lXZXBlWG9tQ1h6S2RjenNVOGhXRUxqLS1aRkpDNVEtUUdZQ1dLcFYtTnlkQlgyVzhCRnRDU1JUdg?oc=5","date":"2023-05-17","type":"pipeline","source":"CGTLive®","summary":"LCAT-GMAC Cell Therapy Improves Symptoms in Patient with Familial LCAT Deficiency - CGTLive®","headline":"LCAT-GMAC Cell Therapy Improves Symptoms in Patient with Familial LCAT Deficiency - CGTLive®","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}